Manifold Bio

formerly Manifold Biotechnologies

Tissue-targeted medicines, designed in vivo

Cambridge, United States · Founded 2020 · $89.4M raised

Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$89.4M
Last Round
$22.0M Extension RoundJan 2024
Rounds
4

About

Platform therapeutics company building an AI-guided in vivo drug discovery engine for tissue-targeted medicines.

Summary

Manifold Bio is a Biotech company based in Cambridge, United States, founded in 2020. It has raised $89.4M in total across 4 rounds, most recently a $22.0M Extension Round round in Jan 2024. Investors include KHK Fund, Triatomic Capital and Playground Global.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Extension RoundExtension RoundJan 2024
$22.0M

Sign up to see all 4 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies